UNIGE document Scientific Article
previous document  unige:115513  next document
add to browser collection
Title

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Authors
Agnandji, Selidji Todagbe
Fernandes, José F
Bache, Emmanuel Bache
Kabwende, Lumeka
Ndungu, Francis Maina
Brosnahan, Jessica
show hidden authors show all authors [1 - 19]
Published in The Lancet Infectious Diseases. 2018, vol. 18, no. 7, p. 738-748
Abstract The recombinant vesicular stomatitis virus (rVSV) vaccine expressing the Zaire Ebola virus (ZEBOV) glycoprotein is efficacious in the weeks following single-dose injection, but duration of immunity is unknown. We aimed to assess antibody persistence at 1 and 2 years in volunteers who received single-dose rVSV-ZEBOV in three previous trials.
Identifiers
PMID: 29627147
Full text
Article (Published version) (252 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Centre de vaccinologie et d'immunologie néonatale (177)
Project Wellcome Trust
Citation
(ISO format)
CSAKI HUTTNER, Angela et al. Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study. In: The Lancet Infectious Diseases, 2018, vol. 18, n° 7, p. 738-748. https://archive-ouverte.unige.ch/unige:115513

79 hits

0 download

Update

Deposited on : 2019-03-29

Export document
Format :
Citation style :